
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1256937-27-5 |
| Catalog No. | 2A-2181930 |
| Chinese Name | Evolocumab |
| Synonyms | Target; PCSK9[1]; References |
| Molecular Formula | C58H97N15O16S2Se |
| Molecular Weight | 1403.572 |
| Boiling Point | 1364.0±75.0 °C at 760 mmHg |
| Storage Condition | -20℃, avoid light |
| Application | Evolocumab (AMG 145) is a human monoclonal antibody that inhibits PCSK9. Evolocumab binds to the circulating PCSK9 protein and inhibits its binding to LDLR. Evolocumab can be used to study hypercholes |
| SMILES | CCCCN=C1NC(=Cc2ccc(-n3cnc(C)c3)c(OC)c2)C(=O)N1C(C)c1ccc(F)cc1.CCN=C1NC(=Cc2ccc(-n3cnc(C)c3)c(OC)c2)C(=O)N1C(C)c1ccc(F)cc1.COC1=NC(=Cc2ccc(-n3cnc(C)c3)c(OC)c2)C(=O)N1C(C)c1ccc(F)cc1.COc1cc(C=C2NC(=NCC3CC3)N(C(C)c3ccc(F)cc3)C2=O)ccc1-n1cnc(C)c1.COc1cc(C=C2NC(=NCCCO)N(C(C)c3ccc(F)cc3)C2=O)ccc1-n1cnc(C)c1 |
| InChI Key | PUHBRGRYFZDQIV-UHFFFAOYSA-N |
| Transport Info | Product name: Evolocumab(anti-PCSK9) |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| N-(2-CARBOXYPHENYL)GLYCINE | 612-42-0 | 2A-1181922 |
| Adalimumab | 331731-18-1 | 2A-0202027 |
| Alirocumab | 1245916-14-6 | 2A-2181927 |
| Denosumab (usan) | 615258-40-7 | 2A-0202030 |
| Eculizumab | 219685-50-4 | 2A-2181929 |
| Lambrolizumab | 1374853-91-4 | 2A-0202209 |
| Ramucirumab | 947687-13-0 | 2A-0202035 |
| Secukinumab | 875356-43-7 | 2A-2181935 |
| Vedolizumab | 943609-66-3 | 2A-2181936 |
| Alemtuzumab | 216503-57-0 | 2A-2181937 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA